CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-10 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −9,000 | 210,505 | ||
| 2022-03-02 | Friedl-Naderer Johanna Chief Business Officer, Global | Grant or award | +90,000 | 90,000 | ||
| 2022-03-02 | Friedl-Naderer Johanna Chief Business Officer, Global | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2022-02-22 | HANLY ANN M. Chief Technology Officer | Grant or award | +53,500 | 84,100 | ||
| 2022-02-22 | HANLY ANN M. Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2022-02-22 | Pang Phillip Chief Medical Officer | Grant or award | +67,000 | 156,768 | ||
| 2022-02-22 | Pang Phillip Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +64,000 | 64,000 | ||
| 2022-02-22 | Rice Steven J. Chief Administrative Officer | Grant or award | +20,000 | 38,658 | ||
| 2022-02-22 | Rice Steven J. Chief Administrative Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-02-22 | Virgin Herbert EVP, Research & CSO | Grant or award | +70,000 | 175,407 | ||
| 2022-02-22 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 176,782 |
| 2022-02-22 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $30.00 | $41K | 175,407 |
| 2022-02-22 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 219,505 | ||
| 2022-02-22 | Virgin Herbert EVP, Research & CSO | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2022-02-22 | Horn Howard CFO | Grant or award | +35,000 | 235,384 | ||
| 2022-02-22 | Horn Howard CFO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-02-18 | SCANGOS GEORGE A President and CEO | Sale | −17,726 | $30.65 | $543K | 112,989 |
| 2022-02-17 | SCANGOS GEORGE A President and CEO | Sale | −10,024 | $31.93 | $320K | 130,715 |
| 2022-02-17 | Virgin Herbert EVP, Research & CSO | Sale | −2,293 | $31.93 | $73K | 105,407 |
| 2022-02-17 | Rice Steven J. Chief Administrative Officer | Sale | −1,942 | $31.93 | $62K | 18,658 |
Page 29 of 54 · 1,063 trades